Development Of The Next Generation Purification Platforms Through Novel Technologies And Holistic Process Engineering
Source: 3M Purification
By Benjamin Kester, Alexei Voloshin, Carl Richey, Dmitri Smirnov, Gregory Jellum, and Kumar Dhanasekharan
Global monoclonal antibody market topped $80 Billion USD in 2013 and is on track to exceed $100 Billion USD in 2015. To sustain and expand this rapid market growth into the future, biopharmaceutical industry requires new generations of highly efficient and robust mAb production processes.
access the Poster!
Log In
Get unlimited access to:
Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue.
X
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.
Subscribe to Bioprocess Online
X
Subscribe to Bioprocess Online
This website uses cookies to ensure you get the best experience on our website. Learn more